Taurus Asset Management Decreased Pfizer (PFE) Position, Commercial Vehicle Group (CVGI) Has 1.03 Sentiment

May 29, 2017 - By Louis Casey

Taurus Asset Management Llc decreased Pfizer Inc (PFE) stake by 4.75% reported in 2016Q4 SEC filing. Taurus Asset Management Llc sold 23,118 shares as Pfizer Inc (PFE)’s stock declined 3.45%. The Taurus Asset Management Llc holds 463,883 shares with $15.07 million value, down from 487,001 last quarter. Pfizer Inc now has $191.28 billion valuation. The stock decreased 0.09% or $0.03 on May 26, reaching $32.14. About 11.70M shares traded. Pfizer Inc. (NYSE:PFE) has declined 2.76% since May 29, 2016 and is downtrending. It has underperformed by 19.46% the S&P500.

Commercial Vehicle Group, Inc. is a supplier of a range of cab-related products and systems. The company has market cap of $246.15 million. The Firm operates through two divisions: the Global Truck and Bus Segment and the Global Construction and Agriculture Segment (GCA Segment). It has a 49.06 P/E ratio. The GTB Segment makes and sells products, which include Seats, Trim, sleeper boxes, cab structures, structural components and body panels, and mirrors and wiper systems.

The stock increased 0.38% or $0.03 on May 26, reaching $7.95. About 174,809 shares traded. Commercial Vehicle Group, Inc. (CVGI) has risen 181.79% since May 29, 2016 and is uptrending. It has outperformed by 165.09% the S&P500.

Since January 1, 0001, it had 0 insider buys, and 2 sales for $125,335 activity.

Ironwood Investment Management Llc holds 1.03% of its portfolio in Commercial Vehicle Group, Inc. for 256,315 shares. Eagle Boston Investment Management Inc owns 969,250 shares or 0.64% of their US portfolio. Moreover, Aristotle Capital Boston Llc has 0.59% invested in the company for 772,600 shares. The Wisconsin-based Netols Asset Management Inc. has invested 0.59% in the stock. Weber Alan W, a New York-based fund reported 148,122 shares.

Investors sentiment decreased to 1.13 in 2016 Q4. Its down 0.05, from 1.18 in 2016Q3. It dropped, as 60 investors sold PFE shares while 672 reduced holdings. 115 funds opened positions while 711 raised stakes. 4.12 billion shares or 1.11% more from 4.08 billion shares in 2016Q3 were reported. Azimuth Management Ltd Limited Liability Company accumulated 496,420 shares. Moreover, Fmr Ltd Liability Corporation has 0.1% invested in Pfizer Inc. (NYSE:PFE) for 21.97 million shares. Raymond James Associate has invested 0.61% in Pfizer Inc. (NYSE:PFE). Benchmark Capital Advsrs has invested 3.21% in Pfizer Inc. (NYSE:PFE). Wendell David Associate holds 0.3% or 46,660 shares in its portfolio. Stuyvesant Cap Management has 6.33% invested in Pfizer Inc. (NYSE:PFE). Verition Fund Mgmt Limited Liability Corporation reported 0.08% in Pfizer Inc. (NYSE:PFE). Prns Ltd Llc owns 196,300 shares for 0.42% of their portfolio. Pioneer Inv Mngmt owns 9.48M shares for 1.08% of their portfolio. Utah Retirement Systems holds 1.10M shares. Alexandria Llc invested 0.06% of its portfolio in Pfizer Inc. (NYSE:PFE). State Bank Of Mellon Corporation stated it has 0.68% in Pfizer Inc. (NYSE:PFE). Graybill Bartz & Assocs reported 91,966 shares stake. Private Wealth Advisors Incorporated holds 0.18% of its portfolio in Pfizer Inc. (NYSE:PFE) for 11,805 shares. Firefly Value Prtn Lp reported 12,025 shares.

Among 19 analysts covering Pfizer (NYSE:PFE), 7 have Buy rating, 0 Sell and 12 Hold. Therefore 37% are positive. Pfizer had 43 analyst reports since July 29, 2015 according to SRatingsIntel. S&P Research maintained the shares of PFE in report on Wednesday, October 28 with “Hold” rating. The company was maintained on Monday, June 20 by Jefferies. The stock has “Market Perform” rating by BMO Capital Markets on Wednesday, November 2. The stock has “Neutral” rating by Suntrust Robinson on Wednesday, November 25. The firm earned “Hold” rating on Thursday, October 13 by Jefferies. The firm earned “Neutral” rating on Monday, April 18 by Goldman Sachs. The firm has “Equal-Weight” rating given on Tuesday, December 1 by Barclays Capital. The rating was upgraded by Morgan Stanley on Friday, October 2 to “Overweight”. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Jefferies on Tuesday, June 14. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by Piper Jaffray on Friday, August 14.

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 1. They expect $0.65 earnings per share, up 1.56% or $0.01 from last year’s $0.64 per share. PFE’s profit will be $3.87B for 12.36 P/E if the $0.65 EPS becomes a reality. After $0.69 actual earnings per share reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -5.80% negative EPS growth.

Since February 27, 2017, it had 0 insider purchases, and 5 sales for $5.16 million activity. Dolsten Mikael had sold 30,970 shares worth $1.07 million on Wednesday, March 1. 20,000 shares were sold by LANKLER DOUGLAS M, worth $693,200 on Thursday, March 2. The insider JOHNSON RADY A sold $153,855. The insider HILL CHARLES H sold 36,000 shares worth $1.23 million.